Header Logo

Connection

PAUL LING to Herpesvirus 4, Human

Back to Details
This is a "connection" page, showing publications PAUL LING has written about Herpesvirus 4, Human.
PAUL LING
Connection Strength
2.915
Herpesvirus 4, Human
  1. EBNA2 and Its Coactivator EBNA-LP. Curr Top Microbiol Immunol. 2015; 391:35-59.
    View in: PubMed
    Score: 0.371
  2. Nuclear-cytoplasmic shuttling is not required for the Epstein-Barr virus EBNA-LP transcriptional coactivation function. J Virol. 2009 Jul; 83(14):7109-16.
    View in: PubMed
    Score: 0.250
  3. Regulation of Sp100A subnuclear localization and transcriptional function by EBNA-LP and interferon. J Interferon Cytokine Res. 2008 Nov; 28(11):667-78.
    View in: PubMed
    Score: 0.242
  4. Epstein-Barr virus DNA loads in adult human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy. Clin Infect Dis. 2003 Nov 01; 37(9):1244-9.
    View in: PubMed
    Score: 0.170
  5. Multiple Epstein-Barr virus infections in healthy individuals. J Virol. 2003 Jun; 77(11):6546-50.
    View in: PubMed
    Score: 0.166
  6. The dynamics of herpesvirus and polyomavirus reactivation and shedding in healthy adults: a 14-month longitudinal study. J Infect Dis. 2003 May 15; 187(10):1571-80.
    View in: PubMed
    Score: 0.165
  7. The EBNA2 polyproline region is dispensable for Epstein-Barr virus-mediated immortalization maintenance. J Virol. 2002 Jul; 76(14):7349-55.
    View in: PubMed
    Score: 0.156
  8. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART. J Med Virol. 2002 Jul; 67(3):320-6.
    View in: PubMed
    Score: 0.156
  9. Notch1IC partially replaces EBNA2 function in B cells immortalized by Epstein-Barr virus. J Virol. 2001 Jul; 75(13):5899-912.
    View in: PubMed
    Score: 0.145
  10. Conserved regions in the Epstein-Barr virus leader protein define distinct domains required for nuclear localization and transcriptional cooperation with EBNA2. J Virol. 2000 Nov; 74(21):9953-63.
    View in: PubMed
    Score: 0.139
  11. First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus. mBio. 2019 09 17; 10(5).
    View in: PubMed
    Score: 0.129
  12. Characterization of the CBF2 binding site within the Epstein-Barr virus latency C promoter and its role in modulating EBNA2-mediated transactivation. J Virol. 1998 Jan; 72(1):693-700.
    View in: PubMed
    Score: 0.114
  13. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1. J Virol. 1994 Sep; 68(9):5375-83.
    View in: PubMed
    Score: 0.091
  14. The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein. Proc Natl Acad Sci U S A. 1993 Oct 15; 90(20):9237-41.
    View in: PubMed
    Score: 0.085
  15. EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif. J Virol. 1993 Jun; 67(6):2990-3003.
    View in: PubMed
    Score: 0.083
  16. Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas. PLoS One. 2011; 6(11):e27271.
    View in: PubMed
    Score: 0.075
  17. Isolation and immortalization of lymphocytes. Curr Protoc Mol Biol. 2005 May; Chapter 28:Unit 28.2.
    View in: PubMed
    Score: 0.047
  18. The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter. J Virol. 2005 Apr; 79(7):4492-505.
    View in: PubMed
    Score: 0.047
  19. EBNA2 is required for protection of latently Epstein-Barr virus-infected B cells against specific apoptotic stimuli. J Virol. 2004 Nov; 78(22):12694-7.
    View in: PubMed
    Score: 0.046
  20. Expression of Epstein-Barr virus latent genes in oral epithelium: determinants of the pathogenesis of oral hairy leukoplakia. J Infect Dis. 2004 Jul 15; 190(2):396-9.
    View in: PubMed
    Score: 0.045
  21. EBNA2 amino acids 3 to 30 are required for induction of LMP-1 and immortalization maintenance. J Virol. 2004 Apr; 78(8):3919-29.
    View in: PubMed
    Score: 0.044
  22. Generation of EBV-specific CD4+ cytotoxic T cells from virus naive individuals. J Immunol. 2002 Jan 15; 168(2):909-18.
    View in: PubMed
    Score: 0.038
  23. Regulation of the Epstein-Barr virus C promoter by AUF1 and the cyclic AMP/protein kinase A signaling pathway. J Virol. 2000 Sep; 74(17):8166-75.
    View in: PubMed
    Score: 0.034
  24. Transcriptional activation signals found in the Epstein-Barr virus (EBV) latency C promoter are conserved in the latency C promoter sequences from baboon and Rhesus monkey EBV-like lymphocryptoviruses (cercopithicine herpesviruses 12 and 15). J Virol. 1999 Jan; 73(1):826-33.
    View in: PubMed
    Score: 0.031
  25. Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucial. Mol Cell Biol. 1995 Nov; 15(11):6150-9.
    View in: PubMed
    Score: 0.025
  26. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa. Science. 1994 Jul 01; 265(5168):92-5.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.